The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening
Laura M. Jacobsen(University of Florida), Jay M. Sosenko(University of Miami), Tandy Aye(Stanford University), Linda A. DiMeglio(Urology of Indiana), John M. Wentworth(The Royal Melbourne Hospital), Mark A. Atkinson(University of Florida), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Darrell M. Wilson(Stanford Medicine), Robin Goland(Columbia University), David Boulware(University of South Florida), Laura E. Bocchino(University of South Florida), Susan Geyer(University of South Florida), William E. Russell(Vanderbilt University)
Cited by 130
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
An Essential Role for Ectodomain Shedding in Mammalian Development
|Science|1998|1.6k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k